George Deboer

2.7k total citations
43 papers, 2.1k citations indexed

About

George Deboer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, George Deboer has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in George Deboer's work include Lung Cancer Research Studies (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). George Deboer is often cited by papers focused on Lung Cancer Research Studies (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). George Deboer collaborates with scholars based in Canada, France and United States. George Deboer's co-authors include William K. Evans, Ronald Feld, Frances A. Shepherd, David Osoba, P Dang, D Perrault, J. David Beatty, W.D. Rider, Izabella Morava-Protzner and John Tsihlias and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and Cancer.

In The Last Decade

George Deboer

42 papers receiving 2.0k citations

Peers

George Deboer
Gerrit DeBoer Canada
J. Mezger Germany
Stacey L. Stern United States
G. Pentheroudakis Greece
Masao Harada Japan
Robert Marsh United States
Robert E. Wittes United States
Jacob D. Bitran United States
Richard L. White United States
Francisco Robert United States
Gerrit DeBoer Canada
George Deboer
Citations per year, relative to George Deboer George Deboer (= 1×) peers Gerrit DeBoer

Countries citing papers authored by George Deboer

Since Specialization
Citations

This map shows the geographic impact of George Deboer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Deboer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Deboer more than expected).

Fields of papers citing papers by George Deboer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Deboer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Deboer. The network helps show where George Deboer may publish in the future.

Co-authorship network of co-authors of George Deboer

This figure shows the co-authorship network connecting the top 25 collaborators of George Deboer. A scholar is included among the top collaborators of George Deboer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Deboer. George Deboer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassam, Zahra, Rebecca Wong, Jolie Ringash, et al.. (2007). A Phase I/II Study to Evaluate the Toxicity and Efficacy of Accelerated Fractionation Radiotherapy for the Palliation of Dysphagia from Carcinoma of the Oesophagus. Clinical Oncology. 20(1). 53–60. 30 indexed citations
2.
Warner, Ellen, Donald B. Plewes, Kylie Hill, et al.. (2004). Effect of age and temporal patterns over 5 years in a Magnetic Resonance Imaging (MRI)-based breast surveillance study for BRCA mutation carriers. Journal of Clinical Oncology. 22(14_suppl). 9500–9500. 3 indexed citations
3.
Choo, Richard, Linda Sugar, George Deboer, et al.. (2003). Is there a progression of histologic grade from radical prostatectomy to local recurrence in patients with clinically isolated local recurrence following surgery?. PubMed. 10(5). 1981–5. 1 indexed citations
4.
Do, Viet, et al.. (2002). Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma. British Journal of Urology. 90(1). 62–67. 15 indexed citations
5.
Hruby, George, Richard Choo, Laurence Klotz, et al.. (2001). The role of serial transrectal ultrasonography in a ‘watchful waiting’ protocol for men with localized prostate cancer. British Journal of Urology. 87(7). 643–647. 15 indexed citations
6.
Choo, Richard, Gerard Morton, Cyril Danjoux, et al.. (1999). 2151 Watchful observation of asymptomatic, favorable grade, prostate carcinoma with selective delayed intervention based on PSA, histologic, and/or clinical progression. International Journal of Radiation Oncology*Biology*Physics. 45(3). 355–355. 6 indexed citations
7.
Chan, Helen S. L., Thomas M. Grogan, George Deboer, et al.. (1996). Diagnosis and reversal of multidrug resistance in paediatric cancers. European Journal of Cancer. 32(6). 1051–1061. 24 indexed citations
8.
Iscoe, N., et al.. (1994). Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?. PubMed. 150(7). 1109–15. 18 indexed citations
9.
Arriagada, R., H Mouriesse, Ali Reza Rezvani, et al.. (1993). Radiotherapy alone in breast cancer. Analysis of tumor and lymph node radiation doses and treatment-related complications. Radiotherapy and Oncology. 27(1). 1–6. 26 indexed citations
10.
Shepherd, Frances A., Robert J. Ginsberg, Riad Haddad, et al.. (1993). Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.. Journal of Clinical Oncology. 11(8). 1592–1597. 60 indexed citations
11.
Sagman, Uri, Michael Lishner, Ellen Maki, et al.. (1992). Second primary malignancies following diagnosis of small-cell lung cancer.. Journal of Clinical Oncology. 10(10). 1525–1533. 61 indexed citations
12.
Sagman, Uri, Ronald Feld, William K. Evans, et al.. (1991). The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.. Journal of Clinical Oncology. 9(6). 954–961. 75 indexed citations
13.
Tannock, Ian F., N F Boyd, George Deboer, et al.. (1988). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.. Journal of Clinical Oncology. 6(9). 1377–1387. 278 indexed citations
14.
Deboer, George, et al.. (1987). Palliation of malignant tracheobronchial obstruction by Nd-YAG laser: an update of experience at the Cleveland Clinic Foundation.. PubMed. 87(3). 226–34. 6 indexed citations
15.
Evans, William K., Frances A. Shepherd, R. Feld, David Osoba, & George Deboer. (1986). First-line therapy with VP-16 and cisplatin for small-cell lung cancer.. PubMed. 13(3 Suppl 3). 17–23. 40 indexed citations
16.
Evans, William K., Ronald Feld, David Osoba, et al.. (1984). VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer. Cancer. 53(7). 1461–1466. 57 indexed citations
17.
Feld, Ronald, et al.. (1982). Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.. PubMed. 65(11-12). 947–54. 23 indexed citations
18.
19.
Deboer, George, Paul S. Miller, & Paul O. P. Ts’o. (1973). Alkyl phosphotriesters of dinucleotides and oligonucleotides. 2. Hydrogen-bonded complexes of adenine and thymine nucleoside alkyl phosphotriesters in deuteriochloroform. Biochemistry. 12(4). 720–726. 14 indexed citations
20.
Deboer, George, et al.. (1970). Reversal mechanisms for the photohydrates of cytosine and its derivatives. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 213(2). 253–268. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerrit DeBoer Breakdown of academic impact, for papers by J. Mezger Breakdown of academic impact, for papers by Stacey L. Stern Breakdown of academic impact, for papers by G. Pentheroudakis Breakdown of academic impact, for papers by Masao Harada Breakdown of academic impact, for papers by Robert Marsh Breakdown of academic impact, for papers by Robert E. Wittes Breakdown of academic impact, for papers by Jacob D. Bitran Breakdown of academic impact, for papers by Richard L. White Breakdown of academic impact, for papers by Francisco Robert
Rankless by CCL
2026